Clinical Trials

NCT05886036 | RECRUITING | PHASE2
70 participants

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2024-01-23
Completion:
2026-10-31
Conditions
  • Nodular Lymphocyte Predominant B-Cell Lymphoma
  • Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma
  • Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT05812807 | RECRUITING | PHASE3
1295 participants

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2023-06-14
Completion:
2033-05-31
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Early Stage Triple-Negative Breast Carcinoma
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • OTHER
  • PROCEDURE
No Results Yet
NCT05677490 | RECRUITING | PHASE3
382 participants

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2023-01-31
Completion:
2028-11-08
Conditions
  • Advanced Esophageal Adenocarcinoma
  • Advanced Gastric Adenocarcinoma
  • Advanced Gastroesophageal Junction Adenocarcinoma
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastric Cancer AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Unresectable Esophageal Adenocarcinoma
  • Unresectable Gastric Adenocarcinoma
  • Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions
  • DRUG
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page